Ryman Healthcare upgraded to neutral from underweight at Jarden (NZ$2.90, -0.01)
Street Takeaways - Ryman Healthcare H1 Earnings (NZ$2.93, +0.01)
Transcript Intelligence: Ryman Healthcare Q2 Earnings Guidance (NZ$2.91, +0.04)
Transcript Intelligence: Ryman Healthcare Q2 Earnings Themes (NZ$2.91, +0.04)
Transcript Intelligence: Ryman Healthcare Q2 Earnings Q&A (NZ$2.91, +0.04)
Ryman Healthcare reports H1 NPAT (NZ$45.2M) vs FactSet (NZ$35M) [1 est] (NZ$2.86, 0.00)
Ryman Healthcare downgraded to underweight from neutral at Jarden (NZ$2.91, 0.00)
StreetAccount Summary - Trading higher/lower: Australia & New Zealand midday
Powered by FactSet Research Systems Inc.